PREDICCt
Research Areas
At a Glance
- Status: Active Consortium
- Year Launched: 2008
- Initiating Organization: Center for Translational Molecular Medicine (CTMM)
- Initiator Type: Government
- Disease focus:
Type 2 Diabetes - Location: Europe
Abstract
Mission
The PREDICCt consortium will combine the latest insights into the causes of Type 2 diabetes mellitus (DM2) with innovative technologies to identify risk-indicators (biomarkers) for DM2 and DM2-related complications, in order to enable (a) stratification of patients at risk of developing diabetes and its cardiovascular complications and (b) development of molecular diagnostics and molecular imaging to identify patients at risk.
Links/Social Media Feed
Other website |
Points of Contact
Marten Hofker
Principal Investigator, PREDICCt project
University Medical Center Groningen (UMCG)
Erna Erdtsieck-Ernste
Program Manager, Cardiovascular Disease
phone: +31 (0)40 800 23 06
Sponsors & Partners
BG Medicine NV |
Da Vinci Europe Laboratory Solutions |
Diagnoptics |
Eindhoven University of Technology |
Fabpulous |
Hycult Biotech |
Leiden University Medical Center |
Maastricht University Medical Center |
Medipark |
MicroScan |
MSD Oss |
Nefrovisie |
Nutricia Research |
Oroboros Instruments GmbH |
Percuros BV |
Radboudumc |
Spinnovation |
TNO: Netherlands Organisation for Applied Scientific Research |
TOPIC Embedded Systems |
University Leiden |
University Medical Center Groningen (UMCG) |
University Medical Center Utrecht |
U-Protein Express BV |